MEDNAX (MD) Misses Q3 EPS by 2c, Guides Q4 EPS Below the Street

MEDNAX (NYSE: MD) reported Q3 EPS of $1.09, $0.02 worse than the analyst estimate of $1.11. Revenue for the quarter came in at $828 million versus the consensus estimate of $821.18 million.

GUIDANCE:

MEDNAX sees Q4 2016 EPS of $1.04-$1.08, versus the consensus of $1.13.

For earnings history and earnings-related data on MEDNAX (MD) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
• Tesla to launch Cybercab in Austin this month - report